Lipid nanoparticles for short interfering RNA delivery
Open accessAbstract
The discovery of RNA interference (RNAi) in mammalian cells has created a new class of therapeutics based on the reversible silencing of specific disease-causing genes. This therapeutic potential depends on the ability to deliver inducers of RNAi, such as short-interfering RNA (siRNA) and micro-RNA (miRNA), to cells of target tissues. This chapter reviews various challenges and delivery strategies for siRNA, with a particular focus on the development of lipid nanoparticle (LNP) delivery technologies. Currently, LNP delivery systems are the most advanced technology for systemic delivery of siRNA, with numerous formulations under various stages of clinical trials. We also discuss methods to improve gene silencing potency of LNP-siRNA, as well as application of LNP technologies beyond siRNA to the encapsulation of other nucleic acids such as mRNA and clustered regularly interspaced short palindromic repeats (CRISPR).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The success of the first approved siRNA-LNP therapeutic and mRNA COVID-19 vaccines originates only from their delivery using ionizable lipid-containing LNPs.
“Based on the potential toxicity of liposomes in clinical application,25,26 the success of the first approved small interfering RNA-lipid nanoparticle (LNP) therapeutic27 and mRNA COVID-19 vaccines originates only from their delivery using ionizable lipid-containing LNPs,28, 29, 30”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Tolentino, M. J., Brucker, A. J., Fosnot, J., Ying, G., WU, I.-H., Malik, G., Wan, S., & Reich, S. J. (2004) · Retina · doi:10.1097/00006982-200402000-00018 · Cited by 173 · see citing works
RetractedTolentino, M. J., Brucker, A. J., Fosnot, J., Ying, G., Wu, I., Malik, G., Wan, S., & Reich, S. J. (2004) · Retina · doi:10.1097/00006982-200408000-00039 · Cited by 31 · see citing works
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852 · see citing works
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · see citing works
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954 · see citing works
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,896 · see citing works
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works
Self-citationDiffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · see citing works
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · see citing works
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · see citing works
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · see citing works
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495 · see citing works
Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5429-5433.1987 · Cited by 2,421 · see citing works
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,189 · see citing works
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098 · see citing works
A microRNA in a Multiple-Turnover RNAi Enzyme Complex
Hutvágner, G., & Zamore, P. D. (2002) · Science · doi:10.1126/science.1073827 · Cited by 2,081 · see citing works
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851 · see citing works
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 5× · see citing works
“FUTURE PROSPECTS 5.1 Avenues for Improving LNP Delivery As mentioned above, tremendous efforts have been invested in the design of ionizable cationic lipids for maximizing the gene silencing capability of LNP-siRNA (Jayaraman et al., 2012; Semple et al., 2010).”
InfluentialSelf-citationBangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,810 · see citing works
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800 · see citing works
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,706 · see citing works
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681 · see citing works
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,644 · see citing works
Waters, L. S., & Storz, G. (2009) · Cell · doi:10.1016/j.cell.2009.01.043 · Cited by 1,599 · see citing works
Schwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424 · see citing works
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · see citing works
Gold nanoparticles: a new X-ray contrast agent
Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. (2006) · British Journal of Radiology · doi:10.1259/bjr/13169882 · Cited by 1,351 · see citing works
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G. T., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,309 · see citing works
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267 · see citing works
Self-citationTargeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,202 · see citing works
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160 · see citing works
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129 · see citing works
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2749 · Cited by 1,011 · see citing works
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974 · see citing works
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971 · see citing works
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 969 · see citing works
Perspective: machines for RNAiPreprint
Tomari, Y., & Zamore, P. D. (2005) · Genes & Development · doi:10.1101/gad.1284105 · Cited by 950 · see citing works
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948 · see citing works
Sorek, R., Kunin, V., & Hugenholtz, P. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1793 · Cited by 909 · see citing works
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908 · see citing works
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 900 · see citing works
Argonaute2 Cleaves the Anti-Guide Strand of siRNA during RISC Activation
Rand, T., Petersen, S., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.10.020 · Cited by 784 · see citing works
Evidence for the role of proteoglycans in cation-mediated gene transfer.
Mislick, K. A., & Baldeschwieler, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12349 · Cited by 774 · see citing works
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2004) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725 · see citing works
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 714 · see citing works
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693 · see citing works
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Côté, M., Misasi, J., Ren, T., Bruchez, A. M., Lee, K., Filone, C. M., Hensley, L. E., Li, Q., Ory, D. S., Chandran, K., et al. (2011) · Nature · doi:10.1038/nature10380 · Cited by 688 · see citing works
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685 · see citing works
Self-citationThe LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein
Beisiegel†, U., Weber, W. T., Ihrke, G., Herz, J., & Stanley, K. K. (1989) · Nature · doi:10.1038/341162a0 · Cited by 680 · see citing works
Decreased plasma cholesterol and hypersensitivity to statins in mice lacking <i>Pcsk9</i>
Rashid, S., Curtis, D. E., Garuti, R., Anderson, N. N., Bashmakov, Y., Ho, Y. K., Hammer, R. E., Moon, Y.-A., & Horton, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501652102 · Cited by 679 · see citing works
Frank-Kamenetsky, M. D., Grefhorst, A., Anderson, N. N., Racie, T., Bramlage, B., Akinc, A., Butler, D., Charissé, K., Dorkin, J. R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 635 · see citing works
Correction of a genetic disease in mouse via use of CRISPR-Cas9
Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D., & Li, J. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.016 · Cited by 614 · cited 1× · see citing works
“Cataract-free mice have been generated by injecting Cas9 mRNA and gRNA targeting the mutated Crygc gene locus into mouse zygotes followed by implantation in surrogate female mice (Wu et al., 2013).”
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601 · see citing works
Self-citationIn vivo activity of nuclease-resistant siRNAs
Layzer, J. M., McCaffrey, A. P., Tanner, A. K., Huang, Z., Kay, M. A., & Sullenger, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 581 · see citing works
Fitzgerald, K. J., Frank-Kamenetsky, M. D., Shulga‐Morskaya, S., Liebow, A., Bettencourt, B. R., Sutherland, J. E., Hutabarat, R. M., Clausen, V. A., Karsten, V., Cehelsky, J. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61914-5 · Cited by 574 · see citing works
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571 · see citing works
Hu‐Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 568 · see citing works
Post-transcriptional gene silencing by siRNAs and miRNAs
Filipowicz, W., Jaśkiewicz, Ł., Kolb, F. A., & Pillai, R. S. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.05.006 · Cited by 562 · see citing works
Molecular Basis for Target RNA Recognition and Cleavage by Human RISC
Ameres, S. L., Martı̂nez, J., & Schroeder, R. (2007) · Cell · doi:10.1016/j.cell.2007.04.037 · Cited by 559 · see citing works
Mui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J. C., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 509 · see citing works
Self-citationVan Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468 · see citing works
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Li, J., Chen, Y.-C., Tseng, Y. C., Mozumdar, S., & Huang, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 467 · see citing works
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Pieken, W. A., Olsen, D. B., Benseler, F., et al. (1991) · Science · doi:10.1126/science.1857967 · Cited by 464 · see citing works
Simple Modifications of Branched PEI Lead to Highly Efficient siRNA Carriers with Low Toxicity
Zintchenko, A., Philipp, A. B., Dehshahri, A., & Wagner, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800065f · Cited by 464 · see citing works
Lipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463 · see citing works
Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S. D., Tavakoli, I., Judge, A. D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 457 · see citing works
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works
Self-citationPhospholipid spherules (liposomes) as a model for biological membranes
Sessa, G., & Weissmann, G. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43097-4 · Cited by 446 · see citing works
DeVincenzo, J. P., Lambkin‐Williams, R., Wilkinson, T. M. A., Cehelsky, J. E., Nochur, S., Walsh, E. E., Meyers, R. E., Gollob, J., & Vaishnaw, A. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 440 · see citing works
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438 · see citing works
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
Li, B.-J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.-J., Woodle, M. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1280 · Cited by 433 · see citing works
Gold Nanoparticle Imaging and Radiotherapy of Brain Tumors in Mice
Hainfeld, J. F., Smilowitz, H. M., O‘Connor, M. J., Dilmanian, F. A., & Slatkin, D. N. (2012) · Nanomedicine · doi:10.2217/nnm.12.165 · Cited by 429 · see citing works
Cullis, P. R., & KRUIJFF, B. D. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90109-8 · Cited by 427 · see citing works
Self-citationThe Liposomal Formulation of Doxorubicin
Abraham, S. A., Waterhouse, D., Mayer, L. D., Cullis, P. R., Madden, T. D., & Bally, M. B. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91004-5 · Cited by 426 · see citing works
Self-citationGregoriadis, G. C. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80394-1 · Cited by 414 · see citing works
The action of steroids and streptolysin S on the permeability of phospholipid structures to cations
Bangham, A. D., Standish, M. M., & Weissmann, G. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80094-8 · Cited by 408 · see citing works
Amstad, E., Kohlbrecher, J., Müller, E., Schweizer, T., Textor, M., & Reimhult, E. (2011) · Nano Letters · doi:10.1021/nl2001499 · Cited by 397 · see citing works
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382 · see citing works
siRNA relieves chronic neuropathic pain
Dorn, G. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh044 · Cited by 380 · see citing works
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 378 · see citing works
Self-citationA novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V., Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368 · see citing works
Thomas, M., Lu, J. J.-Q., Ge, Q., Zhang, C. C., Chen, J., & Klibanov, A. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502067102 · Cited by 366 · see citing works
Lipid polymorphism and the roles of lipids in membranes
Cullis, P. R., Hope, M. J., & Tilcock, C. (1986) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(86)90067-8 · Cited by 364 · see citing works
Self-citationLeung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C. L., Hope, M. J., & Cullis, P. R. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp303267y · Cited by 364 · see citing works
Self-citationTransferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350 · see citing works
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y., Kim, S., Park, H.-O., & Choi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348 · see citing works
Developments in liposomal drug delivery systems
Maurer, N., Fenske, D. B., & Cullis, P. R. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.6.923 · Cited by 344 · see citing works
Self-citationFusion of cationic liposomes with mammalian cells occurs after endocytosis
Wrobel, I., & Collins, D. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80017-a · Cited by 339 · see citing works
Enzyme entrapment in liposomes
Gregoriadis, G. C., Leathwood, P. D., & Ryman, B. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80109-6 · Cited by 330 · see citing works
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier
Kim, Y. H., Park, J. H., Lee, M., Kim, Y., Park, T. G., & Kim, S. W. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.008 · Cited by 328 · see citing works
Rand, T., Ginalski, K., Grishin, N. V., & Wang, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405913101 · Cited by 324 · see citing works
New Class of Polymers for the Delivery of Macromolecular Therapeutics
Gonzalez, H., Hwang, S., & Davis, M. E. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990072j · Cited by 312 · see citing works
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S. P., Kossen, K., Fosnaugh, K. L., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302641 · Cited by 308 · see citing works
A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
Jeffs, L. B., Palmer, L. R., Ambegia, E. G., Giesbrecht, C., Ewanick, S., & MacLachlan, I. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1873-z · Cited by 307 · see citing works
Li, J., Yang, Y., & Huang, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.020 · Cited by 307 · see citing works
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304 · see citing works
Aleku, M., Schulz, P. M., Keil, O., Santel, A., Schaeper, U., Dieckhoff, B., Janke, O., Endruschat, J., Durieux, B., Röder, N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2428 · Cited by 293 · see citing works
Charrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 292 · see citing works
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases
Gregoriadis, G. C., & Ryman, B. E. (1971) · Biochemical Journal · doi:10.1042/bj1240058p · Cited by 286 · see citing works
Stamatatos, L., Leventis, R., Zuckermann, M. J., & Silvius, J. R. (1988) · Biochemistry · doi:10.1021/bi00411a005 · Cited by 286 · see citing works
Li, S., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282 · see citing works
Sproat, B. S., Lamond, A. I., Beijer, B., Neuner, P., & Ryder, U. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.9.3373 · Cited by 271 · see citing works
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 267 · see citing works
Self-citationCationic lipid-mediated transfection of cells in culture requires mitotic activity
Mortimer, I., Tam, P., MacLachlan, I., Graham, R. W., Saravolac, E. G., & Joshi, P. B. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300837 · Cited by 255 · see citing works
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251 · see citing works
Gold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M. L., Kontturi, K., & Urtti, A. O. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 251 · see citing works
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251 · see citing works
DeVincenzo, J. P., Cehelsky, J., Alvarez, R., Elbashir, S. M., Harborth, J., Toudjarska, I., Nechev, L. V., Murugaiah, V., VLIET, A., & Vaishnaw, A. K. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247 · see citing works
Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in Vivo
Mounkes, L. C., Zhong, W., Cipres-Palacin, G., Heath, T. D., & Debs, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26164 · Cited by 245 · see citing works
Webb, M., Harasym, T. O., Masin, D., Bally, M. B., & Mayer, L. D. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.430 · Cited by 243 · see citing works
Tousignant, J. D., Gates, A., Ingram, L., Johnson, C. L., Nietupski, J. B., Cheng, S. H., Eastman, S. J., & Scheule, R. K. (2000) · Human Gene Therapy · doi:10.1089/10430340050207984 · Cited by 237 · see citing works
Thomas, M., Ge, Q., Lu, J. J.-Q., et al. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1874-y · Cited by 236 · see citing works
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X. D., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 233 · see citing works
Maurer, N., Wong, K. F., Stark, H., Louie, L. J., McIntosh, D. P., Wong, T., Scherrer, P., Semple, S. C., & Cullis, P. R. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76202-9 · Cited by 232 · see citing works
Self-citationTan, P.-H., Yang, L.-C., Hc, S., Lan, K.-C., & Cheng, J.-T. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302376 · Cited by 222 · see citing works
Iden, D. L., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00357-1 · Cited by 220 · see citing works
Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery
Hwang, S. J., Bellocq, N. C., & Davis, M. E. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001084 · Cited by 217 · see citing works
Park, S.-H., Oh, S., Mun, J.-Y., & Han, S. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.01.006 · Cited by 212 · see citing works
Thakker, D. R., Natt, F., Hüsken, D., Maier, R., Müller, M., van der Putten, H., Hoyer, D., & Cryan, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406214101 · Cited by 211 · see citing works
Shin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 209 · see citing works
Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, N., Ninio, S., Barenholz, Y., & Lasiç, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037057 · Cited by 207 · see citing works
Baker, A. T., Saltik, M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G. M., Christofori, G., & Cotten, M. L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300471 · Cited by 196 · see citing works
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 195 · see citing works
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & Huang, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195 · see citing works
In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
Audouy, S. A. L., de Leij, L. F. M. H., Hoekstra, D., & Molema, G. (2002) · Pharmaceutical Research · doi:10.1023/a:1020989709019 · Cited by 189 · see citing works
Techniques for encapsulating bioactive agents into liposomes
Mayer, L. D., Bally, M. B., Hope, M. J., & Cullis, P. R. (1986) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(86)90077-0 · Cited by 189 · see citing works
Self-citationWang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189 · see citing works
Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier
Chithrani, D. B., Dunne, M., Stewart, J., et al. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.04.009 · Cited by 187 · see citing works
Microvascular architecture of experimental colon tumors in the rat.
Skinner, S. A., Tutton, P. J. M., & O’Brien, P. E. (1990) · PubMed · Cited by 179 · see citing works
Chen, J., Connor, K. M., Aderman, C. M., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2521 · Cited by 178 · see citing works
Biological barriers to cellular delivery of lipid-based DNA carriers
Bally, M. B., Harvie, P., Wong, F. M. P., et al. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00034-4 · Cited by 171 · see citing works
Pillé, J.-Y., Li, H., Blot, E., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1019 · Cited by 167 · see citing works
Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells
Zou, S., Scarfo, K. A., Nantz, M. H., & Hecker, J. G. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.019 · Cited by 161 · see citing works
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain
Thakker, D. R., Natt, F., Hüsken, D., van der Putten, H., Maier, R., Hoyer, D., & Cryan, J. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001687 · Cited by 159 · see citing works
Elimination Pathways of Systemically Delivered siRNA
Huang, Y., Hong, J., Zheng, S., Ding, Y., Guo, S., Zhang, H., Zhang, X., Du, Q., & Liang, Z. (2010) · Molecular Therapy · doi:10.1038/mt.2010.266 · Cited by 152 · see citing works
Johnston, M., Semple, S. C., Klimuk, S. K., Edwards, K., Eisenhardt, M. L., Leng, E. C., Karlsson, G., Yanko, D., & Cullis, P. R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.009 · Cited by 152 · see citing works
Self-citationLéonetti, J., Machy, P., Degols, G., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2448 · Cited by 151 · see citing works
Davis, M. E., Pun, S., Bellocq, N. C., Reineke, T. M., Popielarski, S. R., Mishra, S., & Heidel, J. D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456179 · Cited by 145 · see citing works
Alvarez, R., Elbashir, S. M., Borland, T. D., Toudjarska, I., Hadwiger, P., John, M., Roehl, I., Shulga‐Morskaya, S., Martinello, R., Kahn, J. S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00014-09 · Cited by 144 · see citing works
Modulation of Membrane Fusion by Asymmetric Transbilayer Distributions of Amino Lipids
Bailey, A. L., & Cullis, P. R. (1994) · Biochemistry · doi:10.1021/bi00208a007 · Cited by 143 · see citing works
Self-citationPillé, J.-Y., Li, H., Blot, E., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-248 · Cited by 140 · see citing works
Parr, M. J., Ansell, S. M., Choi, L. S. L., & Cullis, P. R. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90004-3 · Cited by 134 · see citing works
Self-citationThe role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.137 · Cited by 133 · see citing works
Catecholamine uptake and concentration by liposomes maintaining pH gradients
Nichols, J. L., & Deamer, D. W. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90169-3 · Cited by 130 · see citing works
Systemic Delivery of siRNA via LCP Nanoparticle Efficiently Inhibits Lung Metastasis
Yang, Y., Li, J., Liu, F., & Huang, L. (2011) · Molecular Therapy · doi:10.1038/mt.2011.270 · Cited by 121 · see citing works
Zhang, Y., Schwerbrock, N. M. J., Rogers, A. B., Kim, W. Y., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.120 · Cited by 120 · see citing works
Recent advances of siRNA delivery by nanoparticles
Yuan, X., Naguib, S., & Wu, Z. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559223 · Cited by 113 · see citing works
Low-pH-Sensitive PEG-Stabilized Plasmid−Lipid Nanoparticles: Preparation and Characterization
Choi, J. S., MacKay, J. A., & Szoka, F. C. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025625w · Cited by 109 · see citing works
Tilcock, C., & Cullis, P. R. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90583-6 · Cited by 102 · see citing works
Self-citationTargeting the Blind Spot of Polycationic Nanocarrier-Based siRNA Delivery
Zheng, M., Pavan, G. M., Neeb, M., Schaper, A., Danani, A., Klebe, G., Merkel, O. M., & Kissel, T. (2012) · ACS Nano · doi:10.1021/nn301966r · Cited by 99 · see citing works
Delivery of Therapeutic siRNA to the Lung Endothelium via Novel Lipoplex Formulation DACC
Fehring, V., Schaeper, U., Ahrens, K., Santel, A., Keil, O., Eisermann, M., Giese, K., & Kaufmann, J. (2014) · Molecular Therapy · doi:10.1038/mt.2013.291 · Cited by 97 · see citing works
Hope, M. J., Walker, D. C., & Cullis, P. R. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91253-6 · Cited by 96 · see citing works
Self-citationNovel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells
Chen, Y., Sen, J., Bathula, S. R., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800136v · Cited by 96 · see citing works
Thermodynamics of Polyethylenimine-DNA Binding and DNA Condensation
Utsuno, K., & Uludağ, H. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.04.016 · Cited by 93 · see citing works
Mayer, L. D., Nayar, R., Thies, R. L., Boman, N. L., Cullis, P. R., & Bally, M. B. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686017 · Cited by 87 · see citing works
Self-citationEffects of Apolipoproteins A-IV and A-I on the Uptake of Phospholipid Liposomes by Hepatocytes
Bisgaier, C. L., Siebenkas, M. V., & Williams, K. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85022-6 · Cited by 83 · see citing works
Johnson, S. M., Miller, K. W., & Bangham, A. D. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90023-0 · Cited by 80 · see citing works
Fenske, D. B., Wong, K. F., Maurer, E., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00166-7 · Cited by 75 · see citing works
Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
Nakayama, T., Butler, J. S., Sehgal, A., Severgnini, M., Racie, T., Sharman, J., Ding, F., Shulga‐Morskaya, S., Brodsky, J., Tchangov, L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.33 · Cited by 75 · see citing works
Preparation and characterization of complexes of liposomes with gold nanoparticles
Kojima, C., Hirano, Y., Yuba, E., et al. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.06.022 · Cited by 73 · see citing works
Liposomes containing colloidal gold are a useful probe of liposome-cell interactions
Hong, K., Friend, D. S., Glabe, C. G., et al. (1983) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(83)90220-1 · Cited by 70 · see citing works
Chowrira, B. M., & Burke, J. M. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.11.2835 · Cited by 59 · see citing works
Lingor, P., Michel, U., Schöll, U., Bähr, M., & Kügler, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.170 · Cited by 53 · see citing works
The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo
Rodrigueza, W. V., Pritchard, P. H., & Hope, M. J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90270-a · Cited by 46 · see citing works
Tam, Y. Y. C., Chen, S., Zaifman, J., Tam, Y. K., Lin, P. J. C., Ansell, S., Roberge, M., Ciufolini, M. A., & Cullis, P. R. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.006 · Cited by 44 · see citing works
Self-citationSteinberg, F., Konerding, M. A., & Streffer, C. (1990) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01613005 · Cited by 43 · see citing works
Baker, M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2863 · Cited by 35 · see citing works
Limitations of Cationic Liposomes for Antisense Oligonucleotide Delivery in Vivo
Litzinger, D. C. (1997) · Journal of Liposome Research · doi:10.3109/08982109709035481 · Cited by 32 · see citing works
Amphiphilic polyethylenimine polymers mediate efficient delivery of DNA and siRNA in mammalian cells
Mahato, M., Kumar, P., & Sharma, A. K. (2013) · Molecular BioSystems · doi:10.1039/c3mb25444e · Cited by 30 · see citing works
Liposomal Formulations for Nucleic Acid Delivery
MacLachlan, I. (2007) · CRC Press eBooks · doi:10.1201/9780849387951-16 · Cited by 28 · see citing works
Synthetic Messenger RNA and Cell Metabolism Modulation
Rabinovich, P. M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5 · Cited by 26 · see citing works
Rusk, N. (2012) · Nature Methods · doi:10.1038/nmeth.1916 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works
A Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works
Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332 · see citing works
COVID-19 mRNA vaccines: Platforms and current developments
Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308 · see citing works
Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery
Nogueira, S. S., Schlegel, A., Maxeiner, K., Weber, B., Barz, M., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Ramishetti, S., Peer, D., et al. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01834 · Cited by 252 · see citing works
Viger-Gravel, J., Schantz, A., Pinon, A. C., Rossini, A. J., Schantz, S., & Emsley, L. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b10795 · Cited by 202 · see citing works
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197 · see citing works
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ickenstein, L. M., & Garidel, P. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1669558 · Cited by 193 · see citing works
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside
Zatsepin (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s106625 · Cited by 162 · see citing works
Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives
Kiaie, S. H., Mojarad-Jabali, S., Khaleseh, F., Allahyari, S., Taheri, E., Zakeri-Milani, P., & Valizadeh, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119269 · Cited by 87 · see citing works
Ebenezer, O., Comoglio, P., Wong, G. K.-S., & Tuszynski, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044019 · Cited by 39 · see citing works
- Authors
- Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Cullis, Pieter R.
- ORCID
- Cullis, Pieter R.
- Venue
- Advances in genetics
- Publisher
- Elsevier
- Published
- 2014
- Volume
- 88
- Pages
- 71-110
- ISSN
- 0065-2660 (ISSN-L)
- PMC
- PMC7149983
- OpenAlex
- W2399800494
- Cited by
- 158
- References
- 177
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 11 · 2023: 25 · 2022: 21 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 15 · 2017: 6 · 2016: 9 · 2015: 3
- FWCI
- 7.59
- Type
- book chapter
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Advances in genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- lipid nanoparticles, siRNA delivery, RNA interference, gene silencing, systemic siRNA delivery, microRNA, mRNA encapsulation, CRISPR delivery, nucleic acid delivery systems
- MeSH terms
- Animals, Clinical Trials as Topic, Humans, Lipids, Genetic Therapy, Gene Transfer Techniques, Gene Silencing, RNA Interference, RNA, Small Interfering, Nanoparticles, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review